Munna M, Tahamid Tusar M, Shanta S, Hossain Ahmed M, Sarafat Ali M
J Genet Eng Biotechnol. 2024; 22(3):100406.
PMID: 39179328
PMC: 11372720.
DOI: 10.1016/j.jgeb.2024.100406.
Benjamaa R, Zhu A, Kim S, Kim D, Essamadi A, Moujanni A
BMC Complement Med Ther. 2024; 24(1):261.
PMID: 38987732
PMC: 11238497.
DOI: 10.1186/s12906-024-04566-3.
Gan J, Huang M, Wang W, Fu G, Hu M, Zhong H
J Transl Med. 2024; 22(1):428.
PMID: 38711158
PMC: 11075300.
DOI: 10.1186/s12967-024-05146-2.
Alboabdullah A, Goodarzi M, Homayouni Tabrizi M
Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(9):6623-6631.
PMID: 38483577
DOI: 10.1007/s00210-024-03042-6.
Zhang S, Liu C, Liu D, Ning X, Li H, Zhang X
Mol Biotechnol. 2024; 67(2):496-509.
PMID: 38332433
DOI: 10.1007/s12033-024-01061-5.
Computational markers for personalized prediction of outcomes in non-small cell lung cancer patients with brain metastases.
Benzekry S, Schlicke P, Mogenet A, Greillier L, Tomasini P, Simon E
Clin Exp Metastasis. 2023; 41(1):55-68.
PMID: 38117432
DOI: 10.1007/s10585-023-10245-3.
MicroRNA‑mediated regulation in lung adenocarcinoma: Signaling pathways and potential therapeutic implications (Review).
Liu J, Zhang F, Wang J, Wang Y
Oncol Rep. 2023; 50(6).
PMID: 37859595
PMC: 10603552.
DOI: 10.3892/or.2023.8648.
The antioxidant, anti-angiogenic, and anticancer impact of chitosan-coated herniarin-graphene oxide nanoparticles (CHG-NPs).
Jasim L, Homayouni Tabrizi M, Darabi E, Jaseem M
Heliyon. 2023; 9(9):e20042.
PMID: 37809932
PMC: 10559767.
DOI: 10.1016/j.heliyon.2023.e20042.
HMGB1/SET/HAT1 complex-mediated SASH1 repression drives glycolysis and metastasis in lung adenocarcinoma.
Kou F, Wu L, Zheng Y, Yi Y, Ji Z, Huang Z
Oncogene. 2023; 42(46):3407-3421.
PMID: 37794134
DOI: 10.1038/s41388-023-02850-z.
Interfering with the Expression of Ubiquitin-Like with PHD and Ring Finger Domains 1 Can Inhibit the Invasion of Human Renal Cell Carcinoma.
Wu S, Pan X, Cai Y, Li C
Comput Math Methods Med. 2023; 2022:6971131.
PMID: 37671388
PMC: 10477023.
DOI: 10.1155/2022/6971131.
Phytochemical Profiles and Anticancer Effects of L. Extract Relating to Reactive Oxygen Species Modulation on Patient-Derived Cells from Breast and Lung Cancers.
Ruangsuriya J, Sichaem J, Tantraworasin A, Saeteng S, Wongmaneerung P, Inta A
Scientifica (Cairo). 2023; 2023:6613670.
PMID: 37520043
PMC: 10374377.
DOI: 10.1155/2023/6613670.
The Role of BTBD7 in Normal Development and Tumor Progression.
Liu Y, Song J, Gu J, Xu S, Wang X, Liu Y
Technol Cancer Res Treat. 2023; 22:15330338231167732.
PMID: 37050886
PMC: 10102955.
DOI: 10.1177/15330338231167732.
STRIP2 motivates non-small cell lung cancer progression by modulating the TMBIM6 stability through IGF2BP3 dependent.
Zhang X, Chen Q, He Y, Shi Q, Yin C, Xie Y
J Exp Clin Cancer Res. 2023; 42(1):19.
PMID: 36639675
PMC: 9837939.
DOI: 10.1186/s13046-022-02573-1.
Prognostic significance of tumor-associated macrophages polarization markers in lung cancer: a pooled analysis of 5105 patients.
Yi B, Cheng Y, Chang R, Zhou W, Tang H, Gao Y
Biosci Rep. 2023; 43(2).
PMID: 36633963
PMC: 9902841.
DOI: 10.1042/BSR20221659.
Crizotinib attenuates cancer metastasis by inhibiting TGFβ signaling in non-small cell lung cancer cells.
Park S, Cho E, Chun J, Lee D, Lee S, Kim M
Exp Mol Med. 2022; 54(8):1225-1235.
PMID: 35999455
PMC: 9440021.
DOI: 10.1038/s12276-022-00835-8.
The spatiotemporal dynamics of lung cancer: 30-year trends of epidemiology across 204 countries and territories.
Chen X, Mo S, Yi B
BMC Public Health. 2022; 22(1):987.
PMID: 35578216
PMC: 9109351.
DOI: 10.1186/s12889-022-13281-y.
In silico mutational analysis of ACE2 to check the susceptibility of lung cancer patients towards COVID-19.
Khalid Z, Khan A, Alnajjar R, Santali E, Shakoori A
Sci Rep. 2022; 12(1):7798.
PMID: 35552474
PMC: 9098448.
DOI: 10.1038/s41598-022-11805-5.
Sufentanil inhibits the proliferation and epithelial mesenchymal transition of lung cancer cells through Wnt/beta-catenin signaling pathway.
Guan M, Huang Y, Lin X
Bioengineered. 2022; 13(4):10857-10865.
PMID: 35475399
PMC: 9208446.
DOI: 10.1080/21655979.2022.2066045.
LncRNA HOXC-AS3 promotes non-small-cell lung cancer growth and metastasis through upregulation of YBX1.
Su H, Fan G, Huang J, Qiu X
Cell Death Dis. 2022; 13(4):307.
PMID: 35387975
PMC: 8986809.
DOI: 10.1038/s41419-022-04723-x.
PI3K/Akt/YAP signaling promotes migration and invasion of DLD-1 colorectal cancer cells.
Takeda T, Yamamoto Y, Tsubaki M, Matsuda T, Kimura A, Shimo N
Oncol Lett. 2022; 23(4):106.
PMID: 35242234
PMC: 8848217.
DOI: 10.3892/ol.2022.13226.